We provide a more complete picture of disease risk through clinical-grade whole genome sequencing (up to 30x) and analysis–10x more information than other tests–including rare and common variants and structural alterations
We deliver a lifetime (birth to family planning to late life) of on-demand health insights from a single sample that continuously updates for cardiac, diabetes, autoimmune, cancer risk, and other conditions, response to certain medications, and single gene and polygenic analysis to assess risk of multifactorial diseases
We generate actionable integrated disease risk scores that evolve with a patient’s lifestyle by combining multiple genes and clinical factors enhanced with the newest ML/AI technologies and analysis methods
Estimate the lifetime risk of cardiac disease using genetic markers, clinical history, and lifestyle factors.
Gain new insights over a patient’s lifetime. MyOme analyzes data and provides reports on-demand to answer clinically relevant questions throughout a patient’s life related to risk for common and rare diseases and pharmacogenomics.
Stephen Montgomery, Ph.D.Associate Professor Of Pathology And GeneticsStanford University
Trevor Hastie, Ph.D.Professor Of Statistics And Biomedical Data SciencesStanford University
Russ B. Altman, M.D., Ph.D. Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and Computer ScienceStanford University
Jacob Kitzman, Ph.DAssistant Professor of Human Genetics Assistant Professor of Computational Medicine and Bioinformatics University of Michigan
We are happy to answer any questions. Contact us at *protected email* with any questions or to keep apprised of any development, provide your name and email information.
OFFICE and LAB: Menlo Park, California